Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Vanhove

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Pharmacogenomics Journal|July 6, 2016
Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotypeT Vanhove, P Annaert, D Lambrechts, et al.
Clinical Pharmacology and Therapeutics|April 25, 2017
Fexofenadine, a Putative In Vivo P-glycoprotein Probe, Fails to Predict Clearance of the Substrate Tacrolimus in Renal RecipientsT Vanhove, T Bouillon, H de Loor, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 26, 2016
High Intrapatient Variability of Tacrolimus Concentrations Predicts Accelerated Progression of Chronic Histologic Lesions in Renal RecipientsT Vanhove, T Vermeulen, P Annaert, et al.
Methods of Information in Medicine|June 7, 2014
Platform for efficient switching between multiple devices in the intensive care unitF De Backere, T Vanhove, E Dejonghe, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 23, 2017
Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ RecipientsT Vanhove, H Bouwsma, L Hilbrands, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Pharmacogenomics Journal|July 6, 2016
Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotypeT Vanhove, P Annaert, D Lambrechts, et al.
Clinical Pharmacology and Therapeutics|April 25, 2017
Fexofenadine, a Putative In Vivo P-glycoprotein Probe, Fails to Predict Clearance of the Substrate Tacrolimus in Renal RecipientsT Vanhove, T Bouillon, H de Loor, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 26, 2016
High Intrapatient Variability of Tacrolimus Concentrations Predicts Accelerated Progression of Chronic Histologic Lesions in Renal RecipientsT Vanhove, T Vermeulen, P Annaert, et al.
Methods of Information in Medicine|June 7, 2014
Platform for efficient switching between multiple devices in the intensive care unitF De Backere, T Vanhove, E Dejonghe, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 23, 2017
Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ RecipientsT Vanhove, H Bouwsma, L Hilbrands, et al.
Pageof 1